Stay updated on Belantamab in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Belantamab in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Belantamab in Multiple Myeloma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A new revision entry, Revision: v3.5.4, was added to the Study Record Versions list, replacing the previous Revision: v3.5.3.
    Difference
    0.1%
    Check dated 2026-05-15T03:11:56.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page now shows revision v3.5.3 in place of v3.5.2, indicating a small release update to the record history. This update does not modify study details or other visible content.
    Difference
    0.1%
    Check dated 2026-04-30T17:50:11.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The page history now shows Revision: v3.5.2 as the latest version, replacing Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T10:59:11.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Added revision v3.5.0 to the Record History and removed v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T17:48:30.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The revision label on the page was updated to v3.4.3, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T15:00:54.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    A new revision entry v3.4.2 was added to the history, and a government-funding operating-status notice and the prior revision v3.4.1 were removed.
    Difference
    0.7%
    Check dated 2026-02-11T05:55:37.000Z thumbnail image

Stay in the know with updates to Belantamab in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Belantamab in Multiple Myeloma Clinical Trial page.